Seqvera Ltd. Oy
Budget
€10 — €0
EP Access
0
accredited persons
Staff
1
0.1 FTE
EU Grants
None
Mission & Goals
Seqvera develops and provides solutions for improvement of safety and efficacy of medical devices (2017/745, 2017/746), advanced therapy medicinal products (2007/1394) and health technology assessment (2021/2282) complemented with R&I on elimination of animal testing (2010/63/EC). Seqvera has several patented solutions being implemented in cooperation with H2020 and Horizon Europe projects. Seqvera's goals in cooperation with EU bodies is to foster development and deployment of medical innovations in clinical and healthcare practice to resolve unmet needs, improve cost-efficiency and to provide EU resilience towards security of supply and crises readiness.
EU Legislative Interests
Pharmaceutical strategy for Europe European Health Union EU4Health 3R implementation (2010/63/EC) European Green Deal European Infrastructure for Medicines European Health Emergency Preparedness and Response Authority (HERA) Innovative Health Initiative (IHI)
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
European Orthopaedic Research Society (EORS) European Connected Health Alliance (ECHA) EU chapter of Tissue Engineering and Regenerative Medicine (TERMIS) Expert of the European Commission (REA)
Organisation Members
TechNet Alliance
Additional Information
No EU grants have been received which are related to the activities covered by the register. H2020 and HEU grants are remaining property of the Commission until fulfillment of the projects and are not considered here. Work also have been done on voluntary basis (not paid and not charged)
Commissioner Meetings
No recorded meetings with EU commissioners.